Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Missing material from 1q24q25. | Extra material from 14q32. | High |
| Development | Developmental delay is described; exact pattern varies. | Developmental effects and intellectual disability are described. | Moderate |
| Physical findings | Growth issues are reported; a specific facial pattern is not established. | Distinctive facial features are reported, with other health issues possible. | Moderate |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
Testing identifies a 1q24q25 deletion
The named deletion defines this condition rather than symptoms alone.
High
Severe congenital presentation with growth and developmental concerns
This fits the supplied severity and description, but confirmation is required.
Moderate
Counseling after a confirmed deletion
Care and recurrence discussion should be based on the specific result.
Moderate
Choose 14q32 Duplication Syndrome C4225449 when
Testing identifies extra 14q32 material
A duplication at this region distinguishes it from a 1q deletion.
High
Intellectual disability with distinctive facial features
These are described for the duplication, but are not diagnostic alone.
Moderate
Symptom-focused management after confirmation
The source supports individualized supportive care rather than a fixed regimen.
Moderate
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss at 1q24q25. | Copy-number gain at 14q32. | Best initial distinction; a clinician must interpret size, genes, and parental results. |
| Karyotype | May be normal if the deletion is small. | May be normal if the duplication is small. | A normal karyotype does not exclude either condition. |
| Targeted FISH or region testing | Can support a suspected 1q24q25 deletion. | Can support a suspected 14q32 duplication. | Useful for confirmation or family study when an appropriate probe is available. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Listed as severe, but survival and functional outcome are not quantified.
- Factors
- Deletion extent, involved genes, growth issues, and associated medical needs.
14q32 Duplication Syndrome C4225449
- Outcome
- Listed as moderate, with variable developmental and health effects.
- Factors
- Duplication extent, intellectual disability, facial or other health findings, and support.
Time frame: Usually lifelong and chronic; onset is variable for the deletion and listed as 0-0 for the duplication.
Individual prognosis is not established and requires specialist interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delays may require developmental support. Intellectual disability may require educational support. Severity and specific needs vary; no uniform complication rate is established. |
| Growth and medical complexity | Growth issues and varied medical concerns are described. Other health issues may occur, but exact problems are not specified. Do not infer organ involvement or laboratory abnormalities without evaluation. |
| Family implications | Not communicable; inheritance depends on parental testing. Not communicable; inheritance likewise requires parental studies. Recurrence risk is not established from the supplied data. |
Patient education highlights
- HighConfirmation
Symptoms overlap with many conditions; genetic results and clinician review are needed.
- MediumCare
Management addresses each person’s developmental, growth, and medical needs.
- LowExpectations
Severe or moderate labels do not predict an individual outcome.